Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Jan 27;2(2):168–174. doi: 10.1158/1940-6207.CAPR-08-0107

Figure 3.

Figure 3

The effect of bexarotene on the tumor-producing capabilities of p53 null mammary epithelium in pituitary-isograft bearing mice. Bexarotene significantly delayed tumorigenesis at the high dose (Inline graphic) but not at the low does (Inline graphic) compared to control mice (Inline graphic).